Anil Vij Haryana Health Minister gets a trial dose of Covaxin.
The UAE s Ministry of Health and Prevention (MOHAP) has announced the official registration of the Beijing Institute of Biological Product s Sinopharm COVID-19 vaccine.
An experimental coronavirus vaccine developed by China s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
The Gulf Arab state has been conducting Phase 3 clinical trials of the vaccine since July and in September approved its emergency use for certain groups.
99% seroconversion rate of neutralizing antibody & 100% effectiveness in preventing disease
The Drugs Controller General of India (DCGI) has given conditional approval for Phase 1 and 2 clinical trials of India s first mRNA Covid-19 vaccine candidate HGCO19 that is being developed by Gennova Biopharmaceuticals.